Coloma Jason V 4
4 · Maze Therapeutics, Inc. · Filed Sep 24, 2025
Insider Transaction Report
Form 4
Coloma Jason V
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Units
2025-09-22+100,000→ 100,000 total→ Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The award shall vest as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F3]These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.